This bill mandates the Agency for Health Care Administration to seek federal approval within 30 days of the act becoming law to provide Medicaid coverage for continuous glucose monitors and related supplies as durable medical equipment. It stipulates that licensed durable medical equipment providers must be reimbursed for these monitors, with claims submitted through the Medicare Healthcare Common Procedure Coding System, without the requirement of a National Drug Code number. Additionally, the bill clarifies that the agency can offer further coverage for continuous glucose monitors as a Medicaid pharmacy benefit.

The agency is required to implement these changes promptly upon receiving the necessary federal approval. The act is set to take effect immediately upon becoming law.